Protalix BioTherapeutics (PLX) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.51% |
| Dec 31, 2025 | -34.08% |
| Sep 30, 2025 | 17.23% |
| Jun 30, 2025 | 15.31% |
| Mar 31, 2025 | -20.11% |
| Dec 31, 2024 | 35.10% |
| Sep 30, 2024 | 16.72% |
| Jun 30, 2024 | 43.48% |
| Mar 31, 2024 | 34.56% |
| Dec 31, 2023 | 24.21% |
| Sep 30, 2023 | 40.43% |
| Jun 30, 2023 | 19.95% |
| Mar 31, 2023 | 36.90% |
| Dec 31, 2022 | 58.69% |
| Sep 30, 2022 | 4.90% |
| Mar 31, 2022 | 36.39% |
| Dec 31, 2021 | -47.58% |
| Sep 30, 2021 | -5.15% |
| Jun 30, 2021 | -17.84% |
| Mar 31, 2021 | -9.24% |
| Dec 31, 2020 | -48.27% |
| Sep 30, 2020 | -28.47% |
| Jun 30, 2020 | -16.72% |
| Mar 31, 2020 | 29.67% |
| Mar 31, 2019 | -52.51% |
| Dec 31, 2018 | 3.58% |
| Sep 30, 2018 | -54.02% |
| Jun 30, 2018 | -53.68% |
| Mar 31, 2018 | -64.38% |
| Dec 31, 2017 | -107.86% |
| Sep 30, 2017 | -28.47% |
| Mar 31, 2017 | -54.69% |
| Dec 31, 2016 | 44.99% |
| Sep 30, 2016 | 6.89% |
| Jun 30, 2016 | 7.22% |
| Mar 31, 2016 | -28.47% |
| Dec 31, 2015 | 27.18% |
| Sep 30, 2015 | -27.23% |
| Jun 30, 2015 | -20.11% |